Vident國際股票策略ETF VIDI 深 滬
已收盤 02-06 16:00:00 美东时间
37.22
+0.500
+1.36%
華盛通- 最 高37.32
- 今 開36.95
- 成交量 9365股
- 最 低 36.95
- 昨 收 36.72
- 總市值 4.32亿
- 52周最高 37.49
- 市盈率 靜 --
- 換手率 0.08%
- 52周最低 21.4278
- 委 比 0.00%
- 總股本 1160.00万
- 歷史最高 37.49
- 量 比 0.32
- 振 幅 1.01%
- 歷史最低 6.3118
- 每 手 1
- 風險率 3.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-RTX's Collins Aerospace Activates Advanced Connectivity Services For Thai Airways Fleet Of A321neos
BRIEF-RTX's Collins Aerospace Activates Advanced Connectivity Services For Thai Airways Fleet Of A321neos Feb 3 (Reuters) - Rtx Corp RTX.N : RTX'S COLLINS AEROSPACE ACTIVATES ADVANCED CONNECTIVITY SERVICES FOR THAI AIRWAYS FLEET OF A321NEOS RTX CORP: COLLINS IS PROVIDING GLOBALCONNECT SERVICES ON EA
02-04 05:02
BRIEF-Pepsico Affirms 2026 Financial Outlook
BRIEF-Pepsico Affirms 2026 Financial Outlook Feb 3 (Reuters) - PepsiCo Inc PEP.O : PEPSICO Q4 CORE EPS $2.26 VERSUS IBES ESTIMATE $2.24 PEPSICO Q4 NET REVENUE $29.34 BILLION VERSUS IBES ESTIMATE $28.97 BILLION PEPSICO Q4 ORGANIC REVENUE GROWTH 2.1% PEPSICO: AFFIRMS 2026 FINANCIAL OUTLOOK PEPSICO: 4%
02-03 19:00
BRIEF-Avidity Biosciences Says Record Date Set For February 12, 2026 For Spin-Off
BRIEF-Avidity Biosciences Says Record Date Set For February 12, 2026 For Spin-Off Feb 2 (Reuters) - Avidity Biosciences Inc RNA.O : AVIDITY BIOSCIENCES ANNOUNCES EXPECTED RECORD DATE FOR SPIN-OFF AVIDITY BIOSCIENCES INC - RECORD DATE SET FOR FEBRUARY 12, 2026 FOR SPIN-OFF Source text: ID:nPn20jtppa
02-03 10:46
BRIEF-Informa's Zephyr Enters Into A Strategic Partnership With Aapryl
BRIEF-Informa's Zephyr Enters Into A Strategic Partnership With Aapryl Jan 27 (Reuters) - Zephyr: INFORMA'S ZEPHYR ENTERS INTO A STRATEGIC PARTNERSHIP WITH AAPRYL PROVIDING INVESTMENT PROFESSIONALS WITH CUTTING-EDGE INSIGHTS INTO INVESTMENT SKILL ANALYSIS Source text: ID:nPnfGSyxa Further company co
01-28 02:03
BRIEF-MannKind Announces FDA Approval of Updated Afrezza Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy
BRIEF-MannKind Announces FDA Approval of Updated Afrezza Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy Jan 26 (Reuters) - MannKind Corp MNKD.O : MANNKIND ANNOUNCES FDA APPROVAL OF UPDATED AFREZZA® LABEL PROVIDING STARTING
01-26 19:06
BRIEF-Boeing anticipates cash burn to improve in 2025
Jan 28 (Reuters) - Boeing Co BA.N: BOEING CEO SAYS ALL 3 PRODUCTION LINES IN RENTON ARE NOW CYCLING -- ANALYST CALL BOEING CFO SAYS DELIVERED 33 737 AIRPLANES IN JAN SO FAR BOEING CFO SAYS EXPECT TO B...
2025-01-29 00:07
BRIEF-Lumine Group To Acquire Vidispine From Arvato Systems
Jan 23 (Reuters) - Lumine Group Inc LMN.V: LUMINE GROUP TO ACQUIRE VIDISPINE FROM ARVATO SYSTEMS Source text: ID:nGNXb48tYw Further company coverage: LMN.V (Reuters.Briefs@thomsonreuters.com)
2025-01-24 07:09
BRIEF-Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Jan 8 (Reuters) - Avidity Biosciences Inc RNA.O: AVIDITY BIOSCIENCES ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nPn5SWcf9a Further company coverage: RNA.O ((Reute...
2025-01-09 06:30
RPT-GOLDMAN SACHS EXPECTS COLDER TEMPERATURES IN US AND EUROPE TO BOOST OIL DEMAND BY 0.1MB/D NEXT WEEK
Jan 7 (Reuters) - GOLDMAN SACHS: EXPECTS COLDER TEMPERATURES IN US AND EUROPE TO BOOST OIL DEMAND BY 0.1MB/D NEXT WEEK, PROVIDING FURTHER SUPPORT TO DIESEL PRICES SAYS THEIR CHINA OIL DEMAND NOWCAST S...
2025-01-07 13:11
CORRECTED-GOLDMAN SACHS EXPECTS COLDER WEATHER IN THE US AND EUROPE TO INCREASE OIL DEMAND AND FURTHER SUPPORT DIESEL PRICES (ADDS MISSING WORDS)
Jan 7 (Reuters) - GOLDMAN SACHS: EXPECTS COLDER TEMPERATURES IN US AND EUROPE TO BOOST OIL DEMAND BY 0.1MB/D NEXT WEEK, PROVIDING FURTHER SUPPORT TO DIESEL PRICES SAYS THEIR CHINA OIL DEMAND NOWCAST S...
2025-01-07 13:11
